Status:
RECRUITING
Peer Education for Gender Inclusion and Substance Use in Southern Africa
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
SolidarMed
University of Zambia
Conditions:
Substance Use
Gender Role
Eligibility:
All Genders
16-24 years
Phase:
NA
Brief Summary
The goal of this trial is to test the effectiveness of a brief, behavioral peer group intervention called "PEGISUS" (Peer Education for Gender Inclusion and Substance Use in Southern Africa), on subst...
Detailed Description
Adolescents and young adults (AYA) make up a large proportion of the population in sub-Saharan Africa (SSA), including in South Africa, Zambia, and Zimbabwe, but also face increasingly high levels of ...
Eligibility Criteria
Inclusion
- Adolescents and young adults 16 - 24 years old
- At least weekly self-reported alcohol/drug use in a peer group in the past month or at least monthly heavy episodic drinking with peers over the past three months
- Comfortable communicating in the predominant local language or English
- Lives in the target community and plans to remain in the area for the next 12 months
- Eligible to participate in the vocational training (VT) program (according to the VT program's own entry guidelines) and willing to participate in the entirety of the program
- Interested to participate in a substance reduction and gender equity beliefs program and able to identify 2 to 5 peers to join
- Willing to have PEGISUS workshop sessions audio/video-recorded (if assigned to that group)
Exclusion
- Untreated major mental illness that interferes with study participation, such as active suicidality, or unmanaged bipolar disorder or psychotic disorder
- Currently receiving psychological treatment for substance use
- Participation in another VT/skills development program or another trial that is judged by the site investigator as non-compatible with this study
- Unable to provide informed consent or informed assent
Key Trial Info
Start Date :
September 19 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT06489899
Start Date
September 19 2024
End Date
July 1 2026
Last Update
September 22 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
SOZO Foundation
Cape Town, Western Cape, South Africa, 7975
2
Build It International
Chibombo, Zambia
3
Masvingo Polytechnic
Masvingo, Zimbabwe